JP
Upload

This video is unavailable.

FDA Approves Forest Laboratories, Inc.'s Ceftaroline Medication

FinancialNewsOnline FinancialNewsOnline·14,789 videos
1,883

Subscription preferences

Loading...
Working...
276 views
Like     Dislike 0

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like FinancialNewsOnline's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike FinancialNewsOnline's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add FinancialNewsOnline's video to your playlist.

Uploaded on Nov 1, 2010

The Food and Drug Administration approved Forest Laboratories, Inc.'s (NYSE:FRX) medicine ceftaroline, reports Bloomberg.

The medicine will be used to treat drug-resistant skin infections and bacterial pneumonia.

Forest Laboratories has a potential upside of 4.9% based on a current price of $33.05 and an average consensus analyst price target of $34.67.

Forest's products are marketed in the United States and eastern Europe.

The interactive transcript could not be loaded.
Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

All Comments (0)

Sign in now to post a comment!
  • Loading comment...
Loading...
Loading...
Working...
Sign in to add this to Watch Later